Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05990244 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 2, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jul 1, 2017 to Jan 1, 2017
    • Eligibility criteria shortened, about 16 words
    • Site contact updated
    v5
  2. Primary completion date: Jul 1, 2025 to Jul 1, 2026
    • Study completion date: Jul 1, 2026 to Jul 1, 2027
    • Start date: Jul 1, 2023 to Jul 1, 2017
    v4
  3. Primary completion date: Jul 1, 2024 to Jul 1, 2025
    • Study completion date: Jul 1, 2025 to Jul 1, 2026
    v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Shengjing Hospital
57 trials monitored
See all monitored trials
Glioma
1,251 trials monitored
See 88 trials at risk
Glioblastoma
710 trials monitored
See 52 trials at risk
this study will investigate the relationship between tumor stiffness and adhesion in gliomas using MRE. By utilizing preoperative MRE and Intraoperative neuronavigation, followed by comprehensive molecular pathology analysis, we aim to explore the correlation of tumor stiffness and adhesion with molecular and genetic characteristics of gliomas. Additionally, the predictive value of MRE in terms of pathological staging and prognosis will be determined. This research may pave the way for improved clinical decision-making, personalized treatment approaches, and more accurate clinical trials for glioma patients.
Trial Details
NCT Number NCT05990244
Lead Sponsor Shengjing Hospital
Conditions
(from sponsor)		 Glioma
Related terms Brain Neoplasms, Glioblastoma, Glioma
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov